Infographic: Recombinase Polymerase Amplification in Action

A rapid isothermal amplification technique enables pathogen identification and antibiotic resistance detection in low-resource settings.

Written byHannah Thomasy, PhD
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

A rapid isothermal amplification technique enables pathogen identification and antibiotic resistance detection in low-resource settings.

Recombinase polymerase amplification (RPA) is a technique for rapidly copying segments of DNA. Unlike polymerase chain reaction (PCR), it does not require thermal cycling, so less equipment is needed.

HOW RPA WORKS

Researchers require three defining elements for RPA: uvsX recombinase proteins, single-stranded binding proteins, and strand-displacing DNA polymerases. They also need primers and nucleotides to amplify the target DNA.

Optimal temperature 37-42 degrees celsius
TK

First, the primers bind to the uvsX recombinase proteins to form recombinase-primer complexes.

TK

Then the recombinase inserts the primers into complementary sites in the DNA.

TK

Single-stranded binding proteins bind to the displaced DNA strand and stabilize it.

TK

The recombinase disassembles and the strand-displacing DNA polymerase binds to the 3’ end of the primer.

TK

The polymerase elongates the primer.

TK

The target DNA strands are duplicated.1

RPA APPLICATIONS

Because RPA is rapid, portable, and runs at low temperatures—even body heat can be enough2—it has applications for point-of-care testing for genetics3 and infectious diseases,4 water quality testing,5 antibiotic resistance detection,6 and agricultural pathogen monitoring7.

TK

Point-of-care testing for genetic and infectious diseases

TK

Water quality testing

TK

Antibiotic resistance detection

TK

Agricultural pathogen monitoring

Read the full story.

Related Topics

Meet the Author

  • Hannah Thomasy, PhD headshot

    Hannah is an Assistant Editor at The Scientist. Her work has appeared in The New York Times, The Daily Beast, and Undark. She earned her PhD in neuroscience from the University of Washington where she studied traumatic brain injury and sleep. She completed the Dalla Lana Fellowship in Global Journalism in 2020. Outside of work, she enjoys running and aspires to be a participant on The Great Canadian Baking Show.

    View Full Profile

Published In

December 2023 issue cover
Winter 2023

Ephemeral Life

Recent advances in modeling the human placenta may inform placental disorders like preeclampsia

Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies